Co-Diagnostics, Inc. (CODX:NASDAQ) rocketted at $1.17, a gain of 28.5%. On Thu 09 Jan 20, CODX:NASDAQ touched a New 2-Week Intraday High of $0.95. The stock appeared on our News Catalysts scanner on Tue 07 Jan 20 at 07:59 AM in the 'RECOMMENDATION' category. From Wed 18 Dec 19, the stock recorded 14.29% Up Days and 33.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- CounterPath Corporation (CPAH:NASDAQ), 304.12%
- Origin Agritech Limited (SEED:NASDAQ), 46.92%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 42.67%
- Sorrento Therapeutics, Inc. (SRNE:NASDAQ), 39.59%
- Proteon Therapeutics, Inc. (PRTO:NASDAQ), 30.5%
- Lianluo Smart Limited (LLIT:NASDAQ), 28.57%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 28.54%
- Akari Therapeutics, Plc (AKTX:NASDAQ), 25.43%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 24.97%
- Nektar Therapeutics (NKTR:NASDAQ), 24.69%